Pacing-Induced Cardiomyopathy
12
5
5
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (12)
Left vs Left Randomized Clinical Trial
His Bundle Pacing Versus Right Ventricular Pacing
Pacing to Maintain Physiologic Ventricular Activation
Left Bundle Branch Area Pacing or Biventricular Pacing in AF and Left Ventricular Dysfunction
Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades
LVSP vs RVP in Patients With AV Conduction Disorders
Effect of Leadless Pacing on Heart Function
Effect of Right Ventricle Lead Position on The Psychological Aspects of Patients With A Dual Chamber Pacemaker
Left Bundle Branch Area Pacing in Patients After TAVR
Cardiac ResynchrOniSation Via Stimulation of the LEFT Bundle in AF Patients.
Risk of Pacing-induced Cardiomyopathy
His Pacing Feasibility and Cardiac Electrical Activation